Early Stage Portfolio Management
Pharmagro attended the 2025 Nucleate event in London. Around 20 start-ups presented with a focus on life sciences and agri-tech. Understanding the type of risk of each start-up is important. Themes were that Venture Capitalists are looking for even earlier clinical data. Having a Machine Learning or AI platform is no longer a distinguishing feature.
How we navigated compounding process changes, non-comparable proposals, and hidden CDMO risks.
In just four weeks we provided a strong analysis of CMC elements, embedded in financial, legal and operational issues.
We have made our Pharmagro Portfolio ManagementTool P2MT easier to use! In the Evaluation Section we have added templates. Use these to get started quickly on your evaluations.
See how Pharmagro could help your team structure the uncertainty, explore alternative scenarios and move toward a clearer decision.
